VoxNeuro logo — Giving everyone's brain a voice

VoxNeuro

Giving everyone's brain a voice

Founded 2017 United States Cambridge, United States 9 employees Corporate Round Total: $10.75M Health Care, Medical Devices

General Information

Company Name VoxNeuro
Founded Year 2017
Location United States Cambridge, United States
Employees 9
Industries Health Care, Medical Devices
Funding Stage Corporate Round
Social

BounceWatch is an independent company data service, not affiliated with VoxNeuro. To contact VoxNeuro, visit voxneuro.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does VoxNeuro compare?

A PDF of VoxNeuro and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting VoxNeuro soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About VoxNeuro

VoxNeuro is a Health Care startup, founded in 2017 in the United States, with a mission to "Giving everyone's brain a voice." The company specializes in developing cutting-edge EEG-based brain performance software, aimed at objectively assessing cognitive health. The latest milestone for VoxNeuro came on 03 August 2023, when they secured a significant $4.50M in a corporate round investment from G.Tec Medical Engineering. This recent injection of capital is a testament to the potential seen by investors in VoxNeuro's innovative approach to brain health evaluation and signifies a promising future for the company in the ever-expanding health tech sector.

Business keywords: EEG-based, brain performance software, cognitive health, brain health, physicians, brain-based biomarkers, healthtech, biomarkers, cognitive function, neuroscience

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Corporate Round $4.50M 1
G.Tec Medical Engineering
03 Aug 2023
Grant Undisclosed 1
Center of Aging and Brain Health Innovation
13 Apr 2023
Seed Round $4.00M -
20 Oct 2022
Seed Round $2.00M -
01 Dec 2021
Corporate Round Undisclosed 1
Bay Area Health Trust
29 Oct 2020
Non Equity Assistance Undisclosed 1
Canadian Technology Accelerator
09 Sep 2020
Grant $249.00K 1
National Research Council of Canada Industrial Research Assistance Program
24 Sep 2019

VoxNeuro Alternatives & Competitors

VoxNeuro vs

The NeuroCatch® Platform is a rapid, objective, neuro-physiological brain function assessment system...

7 employees
Biotechnology, Health Care
VoxNeuro vs

Reinventing brain health. Personalized technologies for brain monitoring and stimulation.

Series A
66 employees
AI, Biotechnology
VoxNeuro vs
Intendu
Intendu Israel

Intendu is a digital health company delivering software for brain training targeted at people with b...

Series B
5 employees
Biotechnology, Digital Health

FAQ About VoxNeuro

Giving everyone's brain a voice
VoxNeuro was founded in 2017.
VoxNeuro is headquartered in Cambridge, United States.
VoxNeuro operates in Health Care and Medical Devices. Its work centres on EEG-based, brain performance software, cognitive health and brain health.
VoxNeuro has approximately 9 employees.
VoxNeuro has completed 7 funding rounds, raising a total of $10.75M. The latest funding stage is Corporate Round.
Top alternatives and competitors to VoxNeuro include NeuroCatch®, Neuroelectrics, Intendu, Neroes, Vistim Labs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
VoxNeuro and NeuroCatch® are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for VoxNeuro, https://bouncewatch.com/company/voxneuro, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes